Background: Dizziness and vertigo are frequent complaints of outpatients in the neurological department. Our objective was to explore the epidemiological category and clinical features of patients with dizziness or vertigo in the neurological outpatient department of a tertiary hospital. Methods: We consecutively recruited all patients with dizziness and/or vertigo visiting the neurological outpatient clinic of the First Affiliated Hospital of Chongqing Medical University from January 2016 to June 2017. All patients were interviewed by 4 neurologists and they completed self-administered questionnaires. General physical and standardized neuro-otology bedside examinations were performed in all participants. Instrumental examinations and other related examinations were prescribed as needed. Results: A total of 392 patients, 272 female and 120 male, were enrolled and the ratio of males to females was 1: 2.27. The mean age was 52.39 ± 13.87 years (range 11–90). Elderly patients (≥60 years) accounted for about one-third of the patients. Peripheral vestibular disorders accounted for 54.6% of patients, central vestibular disorders (including vestibular migraine [VM]) accounted for 22.4% of patients, psychogenic vertigo in 64 (16.3%), other reasons in 9 (2.3%) and unknown in 17 (4.3%). Benign paroxysmal positional vertigo (BPPV; 30.8%), psychiatric dizziness (20.5%), and VM (14.4%) were the 3 major vestibular diseases in patients under 60 years of age; however, BPPV (27.9%), central vertigo (21.7%), and Meniere’s disease (11.7%) were more common in patients over 60 years of age. Conclusions: This study provided a classification and clinical features of vestibular disorders in a neurological outpatient department of a tertiary hospital in China. The spectrum of vertigo or dizziness is different between different age groups and clinicians should pay attention to this difference in clinical reasoning.

Keywords:
Classification, Clinical features, Outpatient, Vestibular disorders
1.
Kroenke K, Price RK: Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. Arch Intern Med 1993; 153: 2474–2480.
2.
Yardley L, Owen N, Nazareth I, Luxon L: Prevalence and presentation of dizziness in a general practice community sample of working age people. Br J Gen Pract 1998; 48: 1131–1135.
3.
Hannaford PC, Simpson JA, Bisset AF, et al: The prevalence of ear, nose and throat problems in the community: results from a national cross-sectional postal survey in Scotland. Fam Pract 2005; 22: 227–233.
4.
Mendel B, Bergenius J, Langius-Eklöf A: Dizziness: A common, troublesome symptom but often treatable. J Vestib Res 2010; 20: 391–398.
5.
Wiltink J, Tschan R, Michal M, et al: Dizziness: anxiety, health care utilization and health behavior–results from a representative German community survey. J Psychosom Res 2009; 66: 417–424.
6.
Neuhauser HK, von Brevern M, Radtke A, et al: Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology 2005; 65: 898–904.
7.
Neuhauser HK, Radtke A, von Brevern M, et al: Burden of dizziness and vertigo in the community. Arch Intern Med 2008; 168: 2118–2124.
8.
Agrawal Y, Carey JP, Della Santina CC, Schubert MC, Minor LB: Disorders of balance and vestibular function in US adults: data from the national health and nutrition examination Survey, 2001–2004. Arch Intern Med 2009; 169: 938–944.
9.
Lai YT, Wang TC, Chuang LJ, Chen MH, Wang PC: Epidemiology of vertigo: a national survey. Otolaryngol Head Neck Surg 2011; 145: 110–116.
10.
Bisdorff A, Von Brevern M, Lempert T, Newman-Toker DE: Classification of vestibular symptoms: towards an international classification of vestibular disorders. J Vestib Res 2009; 19: 1–13.
11.
Neuhauser HK: The epidemiology of dizziness and vertigo. Handb Clin Neurol 2016; 137: 67–82.
12.
Brandt T, Dieterich M: The dizzy patient: don’t forget disorders of the central vestibular system. Nat Rev Neurol 2017; 13: 352–362.
13.
Neuhauser HK, Lempert T: Vertigo: epidemiologic aspects. Semin Neurol 2009; 29: 473–481.
14.
Zhang Y, Kong Q, Chen J, et al: International classification of headache disorders 3rd edition beta-based field testing of vestibular migraine in China: demographic, clinical characteristics, audiometric findings and diagnosis statues. Cephalalgia 2016; 36: 240–248.
15.
Jiang H, Deng Y, Zhang Y, et al: Field testing of the ICHD-3β and expert opinion criteria for chronic migraine. J Headache Pain 2016; 17: 85.
16.
Wang J, Huang Q, Li N, et al: Triggers of migraine and tension-type headache in China: a clinic-based survey. Eur J Neurol 2013; 20: 689–696.
17.
Helminski JO, Zee DS, Janssen I, Hain TC: Effectiveness of particle repositioning maneuvers in the treatment of benign paroxysmal positional vertigo: a systematic review. Phys Ther 2010; 90: 663–678.
18.
von Brevern M, Bertholon P, Brandt T, et al: Benign paroxysmal positional vertigo: diagnostic criteria consensus document of the committee for the classification of vestibular disorders of the Bárány society. Acta Otorrinolaringol Esp 2017; 68: 349–360.
19.
Rubin DI, Cheshire WP: Evaluation of “dizziness” in the neurology office. Semin Neurol 2011; 31: 29–41.
20.
von Brevern M, Radtke A, Lezius F, et al: Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry 2007; 78: 710–715.
21.
Chu CH, Liu CJ, Lin LY, Chen TJ, Wang SJ: Migraine is associated with an increased risk for benign paroxysmal positional vertigo: a nationwide population-based study. J Headache Pain 2015; 16: 62.
22.
Baloh RW, Honrubia V, Jacobson K: Benign positional vertigo: clinical and oculographic features in 240 cases. Neurology 1987; 37: 371–378.
23.
Strupp M, Dieterich M, Brandt T: The treatment and natural course of peripheral and central vertigo. Dtsch Arztebl Int 2013; 110: 505–515.
24.
Dieterich M, Staab JP, Brandt T: Functional (psychogenic) dizziness. Handb Clin Neurol 2016; 139: 447–468.
25.
Staab JP, Rohe DE, Eggers SD, Shepard NT: Anxious, introverted personality traits in patients with chronic subjective dizziness. J Psychosom Res 2014; 76: 80–83.
26.
Staab JP: The influence of anxiety on ocular motor control and gaze. Curr Opin Neurol 2014; 27: 118–124.
27.
Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T: The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 2001; 56: 436–441.
28.
Dieterich M, Brandt T: Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol 1999; 246: 883–892.
29.
Teggi R, Colombo B, Albera R, et al: Clinical features, familial history, and migraine precursors in patients with definite vestibular migraine: the VM-phenotypes projects. Headache 2018; 58: 534–544.
30.
Kuritzky A, Toglia UJ, Thomas D: Vestibular function in migraine. Headache 1981; 21: 110–112.
31.
Kayan A, Hood JD: Neuro-otological manifestations of migraine. Brain 1984; 107(pt 4): 1123–1142.
32.
Kerber KA: Vertigo and dizziness in the emergency department. Emerg Med Clin North Am 2009; 27: 39–50, viii.
33.
Newman-Toker DE, Hsieh YH, Camargo CA Jr, et al: Spectrum of dizziness visits to US emergency departments: cross-sectional analysis from a nationally representative sample. Mayo Clin Proc 2008; 83: 765–775.
34.
Kim JS, Lee H: Vertigo due to posterior circulation stroke. Semin Neurol 2013; 33: 179–184.
35.
Lee CC, Su YC, Ho HC, et al: Risk of stroke in patients hospitalized for isolated vertigo: a four-year follow-up study. Stroke 2011; 42: 48–52.
36.
Slater R: Benign recurrent vertigo. J Neurol Neurosurg Psychiatry 1979; 42: 363–367.
37.
Gacek RR, Gacek MR: A classification of recurrent vestibulopathy. Adv Otorhinolaryngol 2002; 60: 89–104.
38.
Nedzelski JM, Barber HO, McIlmoyl L: Diagnoses in a dizziness unit. J Otolaryngol 1986; 15: 101–104.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.